The Josep Carreras Institute and the Hospital del Mar Research Institute strengthen their institutional collaboration August 21, 2025 The Josep Carreras Institute and the Hospital del Mar Research Institute strengthen their institutional collaboration
UFESA donates to the Josep Carreras Leukaemia Research Institute to promote health-related research projects May 10, 2021 UFESA donates to the Josep Carreras Leukaemia Research Institute to promote health-related research projects
Dr. Anna Bigas, among the "Top 100 Women Leaders" April 22, 2021 Dr. Anna Bigas, among the "Top 100 Women Leaders"
Genetic variants identified that impact immune cells’ functioning April 19, 2021 Genetic variants identified that impact immune cells’ functioning
Discovery of Epigenetic Factors Predicting the Severity of COVID-19 April 15, 2021 Discovery of Epigenetic Factors Predicting the Severity of COVID-19
Personalized and precision medicine: the future of tailored treatments discussed at PEMED 2021, chaired by the Josep Carreras Leukaemia Research Institute April 09, 2021 Personalized and precision medicine: the future of tailored treatments discussed at PEMED 2021, chaired by the Josep Carreras Leukaemia Research Institute
Sant Pau administers the first CAR-T of its own production for Hodgkin and non-Hodgkin lymphoma T in Europe March 29, 2021 Sant Pau administers the first CAR-T of its own production for Hodgkin and non-Hodgkin lymphoma T in Europe
Success of the first phase-2 clinical trial testing the new CAR-T technology against multiple myeloma March 26, 2021 Success of the first phase-2 clinical trial testing the new CAR-T technology against multiple myeloma
Emerging leaders in the field of immunity join together at the Josep Carreras Leukaemia Research Institute March 24, 2021 Emerging leaders in the field of immunity join together at the Josep Carreras Leukaemia Research Institute
The Josep Carreras Research Institute and Cytognos S.L. develop a kit to determine the prognosis of patients diagnosed with Acute Myeloid Leukaemia March 03, 2021 The Josep Carreras Research Institute and Cytognos S.L. develop a kit to determine the prognosis of patients diagnosed with Acute Myeloid Leukaemia
